Vivoryon Therapeutics NV Sustainability Reports

Vivoryon Therapeutics NV specializes in developing novel small molecule therapeutics targeting protein misfolding disorders.

Sector: Health Care

Country: Germany

Exchange: Euronext Amsterdam

ISIN: NL00150002Q7

9 reports from 2014 to 2024

• Vivoryon Therapeutics NV 2024 Corporate Governance Report
• Vivoryon Therapeutics NV 2024 Annual Report
• Vivoryon Therapeutics NV 2023 Annual Report
• Vivoryon Therapeutics NV 2022 Annual Report
• Vivoryon Therapeutics NV 2021 Annual Report